Focus: Alcon is a publicly-traded specialty pharmaceutical company headquartered in Fort Worth, TX, focused on eye-care products across ophthalmology and adjacent therapeutic areas. The company generates significant revenue from a concentrated portfolio of glaucoma and ocular inflammation treatments.
Profile data last refreshed 55m ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Alcon to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Alcon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Alcon's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Flagship product generating 43% of company revenue with extended exclusivity through 2034; drives financial stability and valuation.
Minor revenue contributor in inflammation segment with patent protection through 2033; complements core glaucoma franchise.
59 discontinued, 15 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
+12 more products
+2 more
+2 more
+2 more
+2 more
+1 more